These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 14960648)

  • 1. Malignant involvement of the spine: assessment by 18F-FDG PET/CT.
    Metser U; Lerman H; Blank A; Lievshitz G; Bokstein F; Even-Sapir E
    J Nucl Med; 2004 Feb; 45(2):279-84. PubMed ID: 14960648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of malignant skeletal disease: initial experience with 18F-fluoride PET/CT and comparison between 18F-fluoride PET and 18F-fluoride PET/CT.
    Even-Sapir E; Metser U; Flusser G; Zuriel L; Kollender Y; Lerman H; Lievshitz G; Ron I; Mishani E
    J Nucl Med; 2004 Feb; 45(2):272-8. PubMed ID: 14960647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of MR imaging and FDG-PET/CT in the differential diagnosis of benign and malignant vertebral compression fractures.
    Cho WI; Chang UK
    J Neurosurg Spine; 2011 Feb; 14(2):177-83. PubMed ID: 21214309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced ovarian carcinoma: usefulness of [(18)F]FDG-PET in combination with CT for lesion detection after primary treatment.
    Picchio M; Sironi S; Messa C; Mangili G; Landoni C; Gianolli L; Zangheri B; Viganò R; Aletti G; De Marzi P; De Cobelli F; Del Maschio A; Ferrari A; Fazio F
    Q J Nucl Med; 2003 Jun; 47(2):77-84. PubMed ID: 12865867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High predictive value of F-18 FDG PET patterns of the spine for metastases or benign lesions with good agreement between readers.
    Bohdiewicz PJ; Wong CY; Kondas D; Gaskill M; Dworkin HJ
    Clin Nucl Med; 2003 Dec; 28(12):966-70. PubMed ID: 14663317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uptake in supraclavicular area fat ("USA-Fat"): description on 18F-FDG PET/CT.
    Cohade C; Osman M; Pannu HK; Wahl RL
    J Nucl Med; 2003 Feb; 44(2):170-6. PubMed ID: 12571205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of 18F-FDG PET/CT in the evaluation of Ascites of Undetermined Origin.
    Zhang M; Jiang X; Zhang M; Xu H; Zhai G; Li B
    J Nucl Med; 2009 Apr; 50(4):506-12. PubMed ID: 19289438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective digital image fusion of multidetector CT and 18F-FDG PET: clinical value in pancreatic lesions--a prospective study with 104 patients.
    Lemke AJ; Niehues SM; Hosten N; Amthauer H; Boehmig M; Stroszczynski C; Rohlfing T; Rosewicz S; Felix R
    J Nucl Med; 2004 Aug; 45(8):1279-86. PubMed ID: 15299049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18F-FDG accumulation with PET for differentiation between benign and malignant lesions in the thorax.
    Demura Y; Tsuchida T; Ishizaki T; Mizuno S; Totani Y; Ameshima S; Miyamori I; Sasaki M; Yonekura Y
    J Nucl Med; 2003 Apr; 44(4):540-8. PubMed ID: 12679397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solid splenic masses: evaluation with 18F-FDG PET/CT.
    Metser U; Miller E; Kessler A; Lerman H; Lievshitz G; Oren R; Even-Sapir E
    J Nucl Med; 2005 Jan; 46(1):52-9. PubMed ID: 15632034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.
    Fonti R; Salvatore B; Quarantelli M; Sirignano C; Segreto S; Petruzziello F; Catalano L; Liuzzi R; Rotoli B; Del Vecchio S; Pace L; Salvatore M
    J Nucl Med; 2008 Feb; 49(2):195-200. PubMed ID: 18199607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined 18F-FDG and 11C-methionine PET scans in patients with newly progressive metastatic prostate cancer.
    Nuñez R; Macapinlac HA; Yeung HW; Akhurst T; Cai S; Osman I; Gonen M; Riedel E; Scher HI; Larson SM
    J Nucl Med; 2002 Jan; 43(1):46-55. PubMed ID: 11801702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management.
    Bar-Shalom R; Yefremov N; Guralnik L; Gaitini D; Frenkel A; Kuten A; Altman H; Keidar Z; Israel O
    J Nucl Med; 2003 Aug; 44(8):1200-9. PubMed ID: 12902408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
    Metser U; Even-Sapir E
    Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-FDG PET in characterizing adrenal lesions detected on CT or MRI.
    Yun M; Kim W; Alnafisi N; Lacorte L; Jang S; Alavi A
    J Nucl Med; 2001 Dec; 42(12):1795-9. PubMed ID: 11752075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. F-18 FDG PET/CT evaluation of osseous and soft tissue sarcomas.
    Iagaru A; Quon A; McDougall IR; Gambhir SS
    Clin Nucl Med; 2006 Dec; 31(12):754-60. PubMed ID: 17117068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of prebiopsy FDG-PET/CT in discriminating malignant from benign vertebral bone lesions in a predominantly oncologic population.
    Loudini N; Glaudemans AWJM; Jutte PC; Yakar D; Kwee TC
    Skeletal Radiol; 2020 Sep; 49(9):1387-1395. PubMed ID: 32253470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benign nonphysiologic lesions with increased 18F-FDG uptake on PET/CT: characterization and incidence.
    Metser U; Miller E; Lerman H; Even-Sapir E
    AJR Am J Roentgenol; 2007 Nov; 189(5):1203-10. PubMed ID: 17954662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging of oncologic patients: benefit of combined CT and FDG PET in the diagnosis of malignancy.
    Eubank WB; Mankoff DA; Schmiedl UP; Winter TC; Fisher ER; Olshen AB; Graham MM; Eary JF
    AJR Am J Roentgenol; 1998 Oct; 171(4):1103-10. PubMed ID: 9763005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated FDG-PET-CT: its role in the assessment of bone and soft tissue tumors.
    Bischoff M; Bischoff G; Buck A; von Baer A; Pauls S; Scheffold F; Schultheiss M; Gebhard F; Reske SN
    Arch Orthop Trauma Surg; 2010 Jul; 130(7):819-27. PubMed ID: 19636577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.